On the PulseHighlights on biomedical research 
Effectiveness of Pharmacological Treatments for Heart Failure with Reduced Ejection Fraction
BY: Nidhi BiriaJun 15, 2020

Effectiveness of Pharmacological Treatments for Heart Failure with Reduced Ejection Fraction1

 

Despite the appearance of standard treatments for heart failure with reduced ejection fraction (HFrEF), there are still a large number of patients who have progressive deterioration of heart function and, inevitably, end-stage heart failure. In order to evaluate whether patients with HFrEF benefit from medications for treating chronic heart failure, a network meta-analysis was performed. Based on the 32 randomised controlled trials including a pool of 3,810 patients and 32 treatments, the effectiveness of the included pharmacological treatments for optimising the structural performance and improving the cardiac function in the management of patients with HFrEF was confirmed. Briefly, increasing left ventricular ejection fraction (LVEF%) with levosimendan was better than placebo and improved ventricle contraction, controlling and regulating heart rate was better with n-3 polyunsaturated fatty acids (n3-PUFA) and decreasing brain natriuretic peptide (BNP) was better with omega-3 and was the best therapy for improving ventricle wall tension.

 

References

1. Li et al. Medicine (Baltimore). 2020;99(5):e18341.

You May Be Interested In
Watch Out, Plastic May Clog Your Heart!
BY: Benny ChungJun 20, 2024
Venting anger may make you angrier
BY: Benny ChungApr 19, 2024